2nd International Biotechnology Conference
Chalmers Conference Centre.
April 03-05,2019 Gothenburg, Sweden

Sessions

Topics for Conference sessions are listed below

The global biotechnology market is huge, predicted to be US$ 604.4 billion in this year. Biotech market has been sectioned on the basis of applications and technology into segments like- fermentation technology, tissue engineering and regeneration technology, nanobiotechnology, chromatography, cell-based assay, DNA sequencing technology, fingerprinting and enzyme technology and many more. Some of the key areas of biotechnology research include gene therapies, phytoremediation by genetically modified plants, DNA microarray and sequencing technologies, production of monoclonal antibodies, edible vaccines etc., use of high capacity vectors and molecular markers in varied sectors of life sciences and many more.  Emergence of biosimilars and increasing application of biotherapeutics has augmented further expansion of biotechnology sector. Cloning, stem cell technology and nanotechnology are expected to define the future outlook of the market. Molecular diagnosis is seizing an important place in human medical use. Newer biochip-based technologies and biosensors are finding their way in medical biotechnology and health care.
Advanced Microscopic Approaches in Biotechnology
Biosensors
DNA Microarray
DNA Sequencing: Methods and Applications
Edible Vaccines
Engineering Plants for Phytoremediation
Gene Therapy
High Capacity Vectors
Metagenomics
Molecular Markers
Monoclonal Antibody Production and Applications
Proteomics
RNA Interference and Its Applications

Animal biotechnology has applications in the management of several animal diseases and needs to be studied to manage genetic disorders and improve selective animal breeding. Different diagnostics in animal agriculture are also an outcome of animal biotechnology. The most important biotechnology-based products consist of vaccines, particularly genetically engineered or DNA vaccines. Transgenic insects and animals are being explored for direct or indirect human applications. Genomics, proteomics and bioinformatics along with RNA interference technology is now being applied for research in plant and animal biotechnology.

Animal agriculture
Selective breeding
Genetic manipulation and transgenic animals
Somatic cell nuclear transfer
Genetically engineered hormones and vaccines
Animal organs for human patients
Genetically modified insects
Diagnostics in animal agriculture

Biotechnology’s competences for good must be seen in light of its potential for harm. The rapid pace of research and development in varied biotechnology sectors have made it crucial to study their potential impact on society and to attempt development of ethical guidlines. As technology advances, more and more issues surface. Since the inception of human genome project it was decided that the genetic information will be ‘responsibly’ used. In light of the potential social dislocations that might arise from the genetics revolution, organizations have developed ethical guidelines for biotechnology. Especially, bioethics has most significant roles in embryonic stem cells, xenotransplantation and cloning research work.

Genetics revolution and human health
Public trust of biotechnology
Agriculture, food, economics and public health
Ethical, legal and social implications of human genome project
Ethical issues of cloning
Ethical issues of enotransplantation
Bioethics on Embryonic Stem Cells

Under the huge umbrella of “Bioenergy” come multiple industrial sectors stretching from  biomass material producers like agricultural- and forestry-based industries to manufacturers and distributors of biomass-based fuels, products and power and finally to the ultimate consumers. Bio-alcohols, biodiesel, bioethanol, biogas, biomethanol, biohydrogen etc. are the most explored bioenergy sources. Research based on biomass feedstock and conversion processes have geared up in the last couple of decades. Depletion of natural resources coupled with increasing greenhouse emissions has led to greater awareness of the need for sustainable development by reusing waste and biomass and transforming them into valuable materials (valorization) and energy, this area is emerging as a strong trend. Application-wise, the energy segment is presently the largest contributor to the global white biotechnology market owing to the increased demand for bioenergy in developed economies. The overall outcome of biofuel industry is forecasted to be 67 billion gallons by 2022.

Bioalcohols
Biodiesel
Bioethanol
Biogas
Biohydrogen
Biomass Characterization
Biomass Conversion Processes
Biomass Feedstocks
Biomass Fuel Analyses
Biomass Optimization and Valorization
Biomethanol
Bio-oils
Biorefiniery
Chemicals from Biomass
Economic Impact of Biofuels
Environmental Impact of Biofuels
Fuels from Biomass
P-series Fuels
Vegetable Oils
Waste to Bioenergy

Bioprocess technology emphasizes on the application of biological and engineering principles to problems involving microbial, mammalian, and biological/biochemical systems. Bioprocess starts with upstream parameters like isolation of industrial purpose organisms and their strain improvement for enhanced productivities, culture preservation and inoculum development. The successful implementation of microbial fermentation technology from lab to commercial scale requires optimization of a number of variables like aeration and agitation (oxygen transfer rate), H/D of the vessel, tip speed etc. Several reports on mammalian and bacterial fermentations have proved successful in production of biotherapeutics and biosimilars.

Aeration and agitation
Culture preservation and inoculum development
Design of a fermenter
Effluent treatment
Instrumentation and control
Isolation and improvement of industrially microorganisms
Media for industrial fermentations
Microbial growth kinetics
Production of heterologous proteins
Recovery and purification of fermentation products
Sterilization

The pressure on the healthcare industry is increasing globally. Rising incidences of chronic diseases; development of costly clinical innovations; increasing patient awareness and continued economic uncertainty are just a few of the key issues and trends impacting the global health care sector. Thus, there is a need of generic versions of medicinal products which are cost saving analogs of the original products. Monoclonal antibodies, blood products, recombinant hormones, recombinant vaccines, growth factors and gene and cell therapy biological products, all come under the giant umbrella of ‘biopharmaceuticals’. Currently, digital health care and biotechnology is at a great rise. By 2018, it’s estimated that 65% of interactions with health care facilities will occur by mobile devices. It’s predicted that the digital revolution can save $300 billion in spending in the health care sector, especially in the area of chronic diseases. The market value of healthcare sector is forecasted to be US$ 22490 million by 2020.

Biopharmaceutical Manufacturing & Distribution
Biosimilars
Drug Discovery & Development
Food & Drug Administration Review
Personalized Medicine
Vaccines & Biodefence

Intellectual Property Rights is a tool to protect innovation and exploit it to earn money. Costs involved in development of new products and processes is very high, but imitation is possible at lower prices. Thus, for any research-based industry, protection of intellectual property is a very serious issue. The different kinds of intellectual property rights could be categorized as Copyright, Trademark, Geographical indications, Industrial designs, Semiconductor chips and integrated circuits, Patents and Trade secrets. IPR in the pharmaceutical company scenario plays a vital role in the patent filling, legally punishing the counterfeit drug manufacturing industries and establishing the industry name in the market for their drug safety and quality. Some of the leading companies operating in the global intellectual property market are Morrison & Foerter LLP, Irell & Manella LLP, WilmerHale, and Quinn Emanuel Urquhart & Sullivan, LLP. A broad and diverse patent portfolio, combined with flexibility and originality are critical to ensuring a steady stream of capital to biotechnology companies and overcome the roadblocks on the path to commercialization.
Patents
Trade marks
Registered designs
Copy Right and related right
Trade secrets / know-how
Plant breeders' or plant variety rights
Domain names

Under the canopy of medicinal biotechnology, several disciplines of sciences dealing with human diseases- gene therapy, bacteriology and antibiotics, epidemiology, pharmacogenomics etc are included. The strong growth in this sector drives downstream trends in the CMO market. Oncology is the largest therapeutic area and generated 10.7% of all pharmaceutical market revenues in 2015. This is set to increase to 16.3% by 2022. Molecular diagnostics and forensic sciences also have seized good share in the biotech market. Uses of synthetic biology and nanomedicines, gene therapy, monoclonal antibodies, recombinant DNA technology for production of therapeutic proteins, many such severe diseased conditions have been treated.  Over 220 new drugs are expected to be introduced by 2021, which is a positive indication for the outsourced manufacturing sector. Between the start of 2017 and the end of 2021, $147bn of pharmaceutical sales are at risk as several patents are at the verge of expiry.

Bacteriology and Antibiotics
Gene Therapy
Human Diseases and Epidemiology
Immunology and Monoclonal Antibodies
Medical Biotechnology
Molecular Diagnostics and Forensic Science
Pharmacogenomics
Recombinant DNA Technology and Therapeutic Proteins
Stem Cell Technology
Synthetic Biology and Nanomedicine
Tissue Engineering
Virology and Vaccines

Science and entrepreneurship are both acts of experimentation. Both involve taking risks to reach a positive end. Biotech entrepreneurship involves melding of both scientific and business disciplines and involves developing and managing complex systems of knowledge, information and innovation. -Starting a biotech start up is easy but very challenging to grow as it involves tasks like development of business models, growing biotech clusters, procuring regulatory approvals for biotech products, planning the commercialization strategies and finally understanding and securing venture capital. Successful commercialization happens through variety of methods of technology transfers to different levels of product development, product etc. Therefore, the encouragement of risky and long-term capital inflows from investors is important to the continued health of the industry. The recipe for development of entrepreneurship in biotechnology is efforts by Government, Industries, Universities, and Scientific communities in research institutes.

Basic Research Versus Translational Research
Biologics Manufacturing
Biomanufacturing of Biotechnology Products
Biotech Start-Up
Biotechnology Business Models and Managing Risk
Biotechnology Market Development
Biotechnology Product Development
Biotech-Pharma Collaboration
Business Development and Partnering
Commercialization of Bioagricultural Products
Development and Commercialization of In Vitro Diagnostics
Growing Biotechnology Clusters
Intellectual Property Protection Strategies for Biotechnology Innovations
Biotechnology Commercialization Strategies
Regulatory Approval for Biotechnology Products
Understanding and Securing Venture Capital

With greater awareness of environmental issues, many processes are going green. Environmental biotechnology encompasses all approaches adopted to address key environmental issues like bioremediation, enhancement of waste water and integrated aquaculture systems etc. Different biotechnology based strategies have been applied to deal with air and water pollutions, continuously accumulating solid wastes and effluents. Microbial transformations of heavy metals, pesticides and toxins into less polluting moieties and studying their impact on environment is one of the key areas of research. For recovery of some resources bioleaching and bio mining have now gained importance. Continuous efforts are made to get biodegradable plastics one of the major pollutants affecting our environment. Genetically modified bacteria that can degrade different types of effluents are being tested for their efficiencies.

Aquatic Bioassay for Analysis of Pollutants in Surface Waters
Bioaccumulation of Toxicants
Biodegradation of Organic Pollutants
Biodegradation of Pesticides in the Environment
Bioleaching and Biomining for Recovery of Resources
Biological Treatment of Wastewater
Biopesticides and Integrated Pest Management
Biotechnological Approaches to Microalgal Culture
Biotechnology for Solid Waste Management
Biotechnology in Biodiversity Conservation
Environmental Impact of Pollutants and Analysis
Management and Remediation of Problem Soils
Management of Biological Diversity
Microbial Transformation of Heavy Metals
Microbial Transformations of Pesticides
Modeling of Bioreactors
Treatment of Wastewater of the Food Processing Industries

The history of enzyme technology is, of course, an essential part of the history of biotechnology. The global enzymes market is expected to grow on average 4.6 % through 2020 ($7.2 billion). This market includes enzymes used in industrial applications (food and beverages, cleaning products, biofuel production, animal feed, and other markets) and specialty applications (research and biotechnology, diagnostics, and biocatalysts). Biomass conversions also need specific enzymes. Biocatalysis are finding major applications in sustainable chemistry and towards bio based polymers. Food and beverages will remain the largest market for enzymes (immobilization technology), with gains driven by increasing consumption of products containing enzymes in developing regions. The personalized medicine approach requires the increased use of diagnostic testing as well as genomic sequencing, helping to drive strong demand for diagnostic enzymes.

Application of enzymes in solution
Artificial enzymes
Biocatalysis for sustainable chemistry
Biocatalysis towards bio-based polymers
Biomass Conversion
DNA diagnostics
Enzyme discovery and protein engineering
Enzyme production and purification
Enzymes in organic chemistry
Immobilised enzymes and their uses
Plant synthetic biology
Reactors and process technology
Recent advances in enzyme technology
Structural Glycobiology

The growing demand for food coupled with limited availability of nonrenewable natural resources has accelerated the growth of global food biotechnology market in countries like China, US and India. Bio-seeds offer greater advantages compared to conventional seeds and hence will register rapid growth in the agricultural biotechnology segment which is expected to grow at CPGR of 6%.Health conscious people of this generation have directed to a huge market for functional foods and nutraceuticals which is continuously rising. Food biotechnology stretches from fermentation technology (to produce yeast) to valorization of food wastes, from carbon foot print of food to detection of food borne pathogens. Use of biotechnology to create plant breeds with higher yields are also rising in numbers. At the same time ethical and security issues associated with genetically modified crops are also taken account of.

Applications of enzymes in food processing
Carbon footprint of food
Detection and control of foodborne pathogens
Fermentation technology
Functional food and nutraceuticals
GMOs and food security issues
Nanotechnology in food industry
Valorization of food waste

Pharmacogenomics, the study of how genetic variation contributes to an individual’s response to drugs, is an example of how genomics are increasingly relevant in clinical decision-making. DNA profiling and cloning strategies involve the study of genetics for biotechnological applications. Bioinformatics is one such science which take into account the recent advances in high-throughput 'omic technologies (genomics, proteomics and metabolomics) and computer-enabled technologies to generate big data. From which applied data may be put to use for the greater good by developing innovative solutions. Some of the key players in Bioinformatics market include IBM Life Sciences, BIOVIA, Life Technologies Corporation, Agilent technologies and 3rd Millennium. Optimization of PCR program, development of a transgenic animal or plant, screening or analysis of recombinants using blotting and other techniques, all involve applications of genetics in biotechnology.

Bioinformatics
Biotechnological applications of rDNA technology
Cloning strategies
DNA profiling
Gene therapy
Host cells and vectors
Making proteins
Protein engineering
Selection, screening, and analysis of recombinants
The polymerase chain reaction
Transgenic animals
Transgenic plants
Working with nucleic acids

Marine biotechnology involves exploration of seas (the most abundant sources of food and energy production) for innumerable innovations in drug production, ecosystem management, biopolymers and biomaterials and other related fields. Global Marine Biotechnology market is expected to reach $5.9 billion value by 2022 with a CAGR of 6.3%. Several phototrophic marine organisms have been exploited for obtaining enzymes or metabolites of interest. Bioprocesses have been developed to culture the marine organisms from deep sea bed for better understanding from future application point of view. Marine microalgae and seaweed flora have been exploited for several benefits.

Biofouling Control
Bioinformatic Techniques on Marine Genomics
Bioprocess Engineering of Phototrophic Marine Organisms
Corals
Detection of Invasive Species
Marine Enzymes – Production & Applications
Marine Fungal Diversity and Bioprospecting
Marine Metagenome and Supporting Technology
Marine Microalgae
Marine Phototorophs
Marine Sponge Metagenomics
Marine Sponges
Marine Viruses
Microbial Bioprospecting in Marine Environments
Microfluidic Systems for Marine Biotechnology
Novel Bioreactors for Culturing Marine Organisms
Proteomics: Applications and Advances
Seaweed Flora

Discovery of new antibacterial and antifungal agents is a key area of exploration in microbial biotechnology. Microbes have been studied for uses as biofertilizers to promote plant growth, biodegradation agents to degrade effluent wastes, biofuel and biomass productions. The global microbiology testing (diagnostics) market is one of the fast growing areas which is predicted to grow at a CAGR of 8.7% between 2017 and 2025. This rise is because of exponential rise in technological advancements that make microbiology tests faster, cheaper and more accurate. Probiotic organisms have been characterized thoroughly for the varied health benefits they impart on their consumers, including cancer prevention.

Bacterial biocontrol agents
Microbes and Livestock
Microbial amino acids production
Microbial biodegradation
Microbial biofertilizers
Microbial biofuels production
Microbial biomass production
Microbial healthcare products
Microbial production of organic acids
Novel microbial metabolites
Probiotics

Plant biotechnology is an important tool to solve the global problem of hunger! Trees can be engineered to adjust the characteristics of its wood to suit specific needs. Engineering trees so they are more resilient to changing climates and are better able to defend against foreign pests is critical to keep our forests healthy. Growing more material on less land more quickly has potential benefits to the forest products industry, the new liquid biofuels industry, and as a method to sequester carbon more quickly. Bioethics, biosafety and IPR issues related to plant biotechnology are many. There are efforts in direction of developing transgenic plants resistant to droughts and oxidative stress, edible vaccines, enhanced yields and fortified products. Several breeding biotechnologies like pomato, Meyer lemons, rabbage etc. have paved way for new such options.

Agronomic Traits
Biology of Plant Cells
Bioreactors for the Mass Cultivation of Plant Cells
Biosafety, Bioethics, and IPR Issues in Plant Biotechnology
Biotic Stress Tolerance in Plants
Breeding biotechnologies
Drought Associated MicroRNAs in Plants
Genetic Manipulation of Plant Cells
Horticulture Crops and biotechnology
Immobilized Plant Cells
Microbes in Sustainable Agriculture
Molecular Markers in Crop Plants
Oxidative Stress in Plants
Plant Based Edible Vaccines
Plant Genetic Resources
Plant Promoters
Plant Tissue Culture
Plastome Engineering
Transgenic Technology

Stem Cells can self-renew themselves (regenerate) and differentiate or develop into more specialized cells. They are the foundation for every organ and tissue in our body.  Due to this ability of the stem cells, they have tremendous promise to help us understand and treat a wide range of diseases, injuries and other health related problems. Bone marrow transplant is the most widely-used stem cell therapy, followed by therapies derived from umbilical cord blood. Active research is undertaken to explore the effect of Stem cell therapies based on bone marrow, skin and umbilical cord cells in treatment of several disorders like neurodegenerative diseases and conditions such as heart disease, diabetes, etc.  The global stem cell therapy market is forecasted to grow at a CAGR of 39.52% during the period 2017-2021. At the same time ethical issues related to this segment are on a rise.

Dental and craniofacial stem cell research
Ethical issues in stem cell research
Hematopoietic stem cell research
Innovations in tissue engineering & organ regeneration
Nanotechnology in stem cell research
Orthopaedic stem cell therapy
Regeneration and therapeutics
Regenerative medicine
Safety and efficacy of stem cell treatment
Stem cell biomarkers
Stem cell cartilage regeneration
Stem cell metabolism and signaling
Stem cell nano-technology
Stem cell research and regenerative neurology
Stem cell therapy development: clinical trials
Stem cell treatment
Stem cell types and its research
Stem cell-bioinformatics
Stem cells & industry
Stem cells in bone marrow transplantation
Stem cells in cancer research
Stem cells in dermatology
Stem cells in regenerative therapies
Stem cells in tissue repair and regeneration

  • Brochure Download